Mar 29, 2021 7:00 am EDT CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
Mar 26, 2021 9:00 am EDT CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
Feb 25, 2021 9:20 am EST Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants
Feb 18, 2021 7:00 am EST CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares
Feb 11, 2021 11:22 pm EST CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares
Feb 8, 2021 7:00 am EST CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
Dec 10, 2020 7:00 am EST CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications
Dec 1, 2020 7:00 am EST CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update
